Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN

Size: px
Start display at page:

Download "Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN"

Transcription

1 Immediate Postpartum Long-Term Reversible Contraception (LARC) Bethany Berry, CNM, MSN and Alyssa Givens, MSN, RN

2 Disclosures O Bethany Berry CNM is a Nexplanon trainer with Merck O Alyssa Givens, RN has no financial disclosures

3 O Captive audience Why Postpartum Contraception? O Rapid repeat pregnancy is common O 35% of adolescent mothers become pregnant again within 2 years O Most unintended O ½ continue, ½ abortion O Up to 40% no show for postpartum visit Baldwin, Journal of Adolescent Health, 2012

4 Publicly Funded Postpartum Contraception Visits 41% of publicly funded women who had given birth had a contraceptive claim within 3 months 59% Had no funded contraception method postpartum within 3 months of birth.

5 Barriers in Alaska O Distance from remote villages to clinics or hospitals O Weather effecting travel O Untrained providers in villages O No access to providers in villages O Limited travel dates/times O High cost of travel

6

7 Definitions Postpartum: Insertion after delivery, but within 48 hours Postplacental: within 10 minutes after expulsion of the placenta after vaginal delivery Delayed Postpartum Insertion: after the post-placental period, but within 48 hours of delivery and before the client leaves the hospital Transcesarean: following a cesarean delivery, before the uterus is sutured

8 IUD Insertion Postpartum O 15 studies O Copper IUD compared to different time periods O Immediate (within 10 minutes) lower expulsion rates than later in the postpartum period O No increase in complications = SAFE O Bleeding, infection, perforation O Expulsion lower with trans-cesarean than vaginal delivery (not necessarily )

9 Expulsion O 2-8% in the first year of use with interval insertion. O Expulsion rates <10% if post-partum IUD inserted within 10 minutes of placental delivery O Expulsion rates 2-37% if placed 2-72 hours after delivery. O Provider experience has a major influence on expulsion rates Grimes DA, Lopez LM, Schulz KF, Van Vliet HA, Stanwood NL. Immediate post-partum insertion of intrauterine devices. Cochrane Database of Systematic Reviews 2010, Issue 5.

10 IUD: Why 10 minutes? Adjusted cumulative expulsion rates <= 10 min 2-23 hr hr hr P<0.001 Chi Contraception 1985

11 Expulsion Women generally recognize an expulsion IUD can be reinserted before 48 hours or after 4 weeks if there is an expulsion Counsel women about breastfeeding as contraception, and provide condoms/ecp as backup

12 Postpartum IUD Insertion Advantages Women are motivated to contraception Not pregnant Insertion is simple (Sort of ) Disadvantages Higher expulsion rate May be offset by higher proportion of patients actually getting an IUD inserted

13 Contraindications O Chorioamnionitis O Prolonged rupture of membranes O Prolonged labor O Endometritis/sepsis O Hemorrhage O Severe perineal laceration

14 Learning PP IUD Insertion

15 Uterus: Immediately Postpartum

16 Post-placental Manual Insertion O Within 10 minutes of placental delivery if possible O The cervix is open and limp O Allows for the passage of the hand O Placement of the IUD high in the fundus O String length

17 Manual Insertion

18 Manual Insertion

19

20

21 Insertion with Ring Forceps

22

23

24 Trans-Cesarean Insertion Place the IUD with the inserter

25 Implant: Nexplanon Off Label Use

26 Postpartum Nexplanon O Can be placed immediately postpartum or just prior to discharge home O Little research on effects of etonorgestrel on breast milk or breastfeeding O Reimbursement Issues

27 What About Breastfeeding?

28 Impact on Breastfeeding According to the Academy of Breastfeeding Medicine there is a theoretical impact on breastmilk production with progestin methods (LNG IUD and Etonorgestrel Implant).

29 ANMC Satisfaction Data 73 women who received postpartum LARCs (IUCs and implants) over a 3 month period. A phone survey was conducted to evaluate satisfaction and continuation 12 months after insertion/delivery.

30 Immediate PP IUD Satisfaction/Continuation Urban Rural 83% 66% 80% 75%

31 Immediate PP Implant Satisfaction/Continuation Urban Rural 42% 69% 50% 69%

32 Conclusions of Study O The satisfaction and continuation rates of the IUD were high among both urban and rural women. O The satisfaction and continuation rates of the implant were lower for both urban and rural women, but still substantial.

33

34 Questions?

35 Qaĝaasakung Aleut Quyanaq Inupiaq Chin an Dena ina Athabascan Thank You!!!

Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION

Postpartum LARC. (Long Acting Reversible Contraception) NURSING EDUCATION Postpartum LARC (Long Acting Reversible Contraception) NURSING EDUCATION What is LARC Long-acting reversible contraception (LARC) methods include the intrauterine device (IUD) and the birth control implant.

More information

Example Clinical Guideline for Immediate Postpartum LARC Insertion

Example Clinical Guideline for Immediate Postpartum LARC Insertion Example Clinical Guideline for Immediate Postpartum LARC Insertion RATIONALE Delay in contraceptive provision until the six week postpartum appointment can leave some women at risk for rapid repeat pregnancy.

More information

Road to Access: Successes and Challenges in implementation of IPP LARC. Eve Espey, MD MPH New Mexico Perinatal Collaborative ILPQC

Road to Access: Successes and Challenges in implementation of IPP LARC. Eve Espey, MD MPH New Mexico Perinatal Collaborative ILPQC Road to Access: Successes and Challenges in implementation of IPP LARC Eve Espey, MD MPH New Mexico Perinatal Collaborative ILPQC 11-5-18 OR. If at first you don t succeed, try try again Disclosures and

More information

Example CLINICAL GUIDELINES for Postpartum IUD insertion

Example CLINICAL GUIDELINES for Postpartum IUD insertion Example CLINICAL GUIDELINES for Postpartum IUD insertion Postpartum Intrauterine Device Insertion 1.0 Indications: 1.1 Insertion of an intrauterine device (IUD) for long-acting reversible contraception

More information

The number of women using long-acting reversible

The number of women using long-acting reversible Long-acting reversible contraception: Who, what, when, and how This review provides practical tips and dispels some common misconceptions about these devices, which have higher rates of patient satisfaction

More information

ACCESS LARC INCREASING ACCESS TO IMMEDIATE POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTION

ACCESS LARC INCREASING ACCESS TO IMMEDIATE POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTION ACCESS LARC INCREASING ACCESS TO IMMEDIATE POSTPARTUM LONG-ACTING REVERSIBLE CONTRACEPTION Chapter Four: Policies and Procedures Overview This procedure outline is a pre-cursor to detailed procedures related

More information

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use

Unintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use 3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common

LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common 4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial

More information

VCHIP LARC Needs Assessment Survey

VCHIP LARC Needs Assessment Survey VCHIP LARC Needs Assessment Survey Demographics 1. How many have you been in practice (post-training)? Choose one of the following answers 0-5 6-10 11-15 16-20 21 or more 2. What are your professional

More information

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok

Simplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Simplifying Vide Contraception University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Background Objectives At the conclusion of this presentation participants will be able

More information

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings.

The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings. The Balanced Counseling Strategy Plus: A Toolkit for Family Planning Service Providers Working in High STI/HIV Prevalence Settings Counseling Cards Checklist to be reasonably sure a woman is not pregnant

More information

Dedicated postpartum IUD inserter. Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016

Dedicated postpartum IUD inserter. Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016 Dedicated postpartum IUD inserter Dr. Anne Burke, Johns Hopkins Medicine Dr. Leo Han, OHSU Healthcare July 13, 2016 Unmet need for FP in postpartum period Across 27 countries, 65% of postpartum women had

More information

Medical Eligibility for Contraception Use

Medical Eligibility for Contraception Use Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist

More information

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE

Contraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)

More information

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH

BRIEF REPORTS. Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH Providing Long-Acting Reversible Contraception in an Academic Family Medicine Center Jennifer Amico, MD, MPH; Justine Wu, MD, MPH BACKGROUND AND OBJECTIVES: Providing long-acting reversible contraception

More information

Lindsey Tingen, MD Department of Obstetrics and Gynecology, Greenville Health System Greenville, SC

Lindsey Tingen, MD Department of Obstetrics and Gynecology, Greenville Health System Greenville, SC Postpartum IUD Insertion: Continued Usage at Six Months Based on Expulsion and Removal Rates at Greenville Memorial Hospital in the First Year After Adoption of the Practice Lindsey Tingen, MD Department

More information

U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Division of Reproductive Health Centers for Disease Control and Prevention August 1, 2013 National Center for Chronic Disease Prevention and

More information

Postpartum intrauterine device placement: a patient-friendly option

Postpartum intrauterine device placement: a patient-friendly option Cwiak and Cordes Contraception and Reproductive Medicine (2018) 3:3 https://doi.org/10.1186/s40834-018-0057-x Contraception and Reproductive Medicine REVIEW Postpartum intrauterine device placement: a

More information

MIDWIVES IN CONTRACEPTION AND FERTILITY PLANNING 15 TH ANNUAL SOMSA CONGRESS BLOEMFONTEIN AUGUST 2018

MIDWIVES IN CONTRACEPTION AND FERTILITY PLANNING 15 TH ANNUAL SOMSA CONGRESS BLOEMFONTEIN AUGUST 2018 MIDWIVES IN CONTRACEPTION AND FERTILITY PLANNING 15 TH ANNUAL SOMSA CONGRESS BLOEMFONTEIN AUGUST 2018 Contraception is every health care workers responsibility # SOMSA Congress: Quality and Respectful

More information

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH

The Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria

More information

WEST VIRGINIA POSTPARTUM LARC TOOLKIT

WEST VIRGINIA POSTPARTUM LARC TOOLKIT WEST VIRGINIA POSTPARTUM LARC TOOLKIT A RESOURCE FOR PROVIDING LONG-ACTING REVERSIBLE CONTRACEPTIVE (LARC) SERVICES IN THE HOSPITAL POSTPARTUM SETTING This toolkit contains information that may expand

More information

Comparative study of interval versus postpartum Cu-T insertion in a central referral hospital of North East India

Comparative study of interval versus postpartum Cu-T insertion in a central referral hospital of North East India International Journal of Reproduction, Contraception, Obstetrics and Gynecology Lucksom PG et al. Int J Reprod Contracept Obstet Gynecol. 2015 Feb;4(1):47-51 www.ijrcog.org pissn 2320-1770 eissn 2320-1789

More information

Immediate postplacental intra-uterine device insertion

Immediate postplacental intra-uterine device insertion Immediate postplacental intra-uterine device insertion Solene Vigoureux, Marie-Emmanuelle Neveu, Nathalie Kekikoglu, Sophie Gaudu Team from Bicêtre FIAPAC Nantes 15 Septembre 2018 Should we talk about

More information

Intrauterine Devices (IUDs): Access for Women in the U.S.

Intrauterine Devices (IUDs): Access for Women in the U.S. November 2016 Fact Sheet Intrauterine Devices (IUDs): Access for Women in the U.S. Intrauterine devices (IUDs) are one of the most effective forms of reversible contraception. IUDs, along with implants,

More information

Examining Long-Acting Reversible Contraceptive Methods

Examining Long-Acting Reversible Contraceptive Methods Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/examining-long-acting-reversible-contraceptivemethods/7078/

More information

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: Review Article ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON INTRAUTERINE DEVICES Boddu Venkata Komali* 1, M. Kalyani

More information

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines

Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion LNG-IUS is an effective contraceptive;

More information

Day of Learning: Current Best Practices for Contraceptive Provision

Day of Learning: Current Best Practices for Contraceptive Provision Day of Learning: Current Best Practices for Contraceptive Provision Thank you to our Sponsors Carnegie Science Center Jewish Healthcare Foundation Allegheny Health Network s Center for Inclusion Health

More information

Instruction for the patient

Instruction for the patient WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left

More information

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables

LONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper

More information

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck

Disclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck ADOLESCENT CONTRACEPTION UPDATE APRIL 28, 2017 Brandy Mitchell, MN, RN, ANP BC, WHNP BC University of Iowa Hospitals and Clinics Obstetrics and Gynecology Iowa Association of Nurse Practitioners Spring

More information

The use of long-acting reversible contraceptive

The use of long-acting reversible contraceptive Overcoming LARC complications: 7 case challenges The strings to your patient s intrauterine device (IUD) are missing. Clinical experience and ACOG direction guide the management plans for this and more

More information

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40 CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures

More information

Contraception for Adolescents: What s New?

Contraception for Adolescents: What s New? Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing

More information

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide

More information

Extended use of intrauterine devices: How long can we go?

Extended use of intrauterine devices: How long can we go? Extended use of intrauterine devices: How long can we go? Justine P. Wu, MD, MPH Sarah Pickle, MD Rutgers Robert Wood Johnson Medical School Department of Family Medicine & Community Health Disclosures

More information

International Federation of Gynecology and Obstetrics

International Federation of Gynecology and Obstetrics International Federation of Gynecology and Obstetrics THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION THE ROLE OF POST- ABORTION CONTRACEPTION IN PREVENTION OF UNSAFE ABORTION

More information

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures

LARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco

More information

Aim For the Bullseye: Presented on 2/10/2016 for the NC Child Fatality Task Force. LARC and Pregnancy Prevention in NC

Aim For the Bullseye: Presented on 2/10/2016 for the NC Child Fatality Task Force. LARC and Pregnancy Prevention in NC Aim For the Bullseye: Presented on for the NC Child Fatality Task Force LARC and Pregnancy Prevention in NC 2 What is LARC? 3 L=Long A=Acting R=Reversible C=Contraception 4 Learning Objectives Describe

More information

Long Acting Reversible Contraception: First Line Care for Adolescents. David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG

Long Acting Reversible Contraception: First Line Care for Adolescents. David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG Long Acting Reversible Contraception: First Line Care for Adolescents David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG Disclosures Melissa Kottke is a Nexplanon trainer for Merck Objectives Describe

More information

LARC Quick Coding Guide Supplement

LARC Quick Coding Guide Supplement LARC ICD-10 Coding Reference Basic Implant Codes ICD-10 Codes Implant CPT Procedure Codes HCPCSII/JCode Z30.017 Encounter for initial prescription of other contraceptives (includes 11981 - insertion J7307

More information

Review of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016

Review of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016 Review of IUCD Complications: Lessons from CAT Dr FG Mhlanga CAT Meeting 24 September 2016 INTRODUCTION The intrauterine device (IUD) is a reliable long term reversible, cost-effective,easy to use and

More information

RESOLUTION NO. 301 (Co-Sponsored G) SUBSTITUTE ADOPTED See Below

RESOLUTION NO. 301 (Co-Sponsored G) SUBSTITUTE ADOPTED See Below RESOLUTION NO. 301 (Co-Sponsored G) SUBSTITUTE ADOPTED See Below Support Placement and Coverage of Long-Acting Reversible Contraceptives (LARC) in the Early Postpartum Period Introduced by the California

More information

Contraceptive Updates and Recommendations

Contraceptive Updates and Recommendations Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,

More information

Contraceptive Updates and Recommendations

Contraceptive Updates and Recommendations Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,

More information

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014

Contraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014 Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits

More information

ASTHO LARC Learning Community Virtual Learning Session Training. February 19, :00-4:00p ET , ext #

ASTHO LARC Learning Community Virtual Learning Session Training. February 19, :00-4:00p ET , ext # ASTHO LARC Learning Community Virtual Learning Session Training February 19, 2014 2:00-4:00p ET 866-740-1260, ext. 5273187# Agenda 2:00 Welcome and Introductions 2:10 State Team Updates 2:40 State Presentation:

More information

Adolescent Hot Topics: Contraception

Adolescent Hot Topics: Contraception Adolescent Hot Topics: Contraception Dr. Stephanie Addison Holt Adolescent Medicine Objectives Discuss way to counsel the sexually active adolescent Explore the latest recommendations and updates regarding

More information

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows

Family Planning UNMET NEED. The Nurse Mildred Radio Talk Shows Family Planning UNMET NEED The Nurse Mildred Radio Talk Shows TOPIC 9: IUD/COIL Guests FP counsellor from MSU, RHU& UHMG Nurse Mildred Nurse Betty Objectives of the programme: To inform listeners about

More information

Dr. Russo reports no financial relationships relevant to this article. Dr Creinin is a senior clinical advisor for Medicines360.

Dr. Russo reports no financial relationships relevant to this article. Dr Creinin is a senior clinical advisor for Medicines360. CONTRACEPTION Demand for long-acting reversible contraception is growing, including in adolescents and nulliparas. We need to challenge our historical reservations about the IUD and heed the call. Jennefer

More information

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)

FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Mirena does not protect against HIV infection (AIDS) and other sexually transmitted infections

More information

Meeting Unmet Need and Increasing Contraceptive Options and Services with Postpartum Family Planning

Meeting Unmet Need and Increasing Contraceptive Options and Services with Postpartum Family Planning Meeting Unmet Need and Increasing Contraceptive Options and Services with Postpartum Family Planning Roy Jacobstein, MD, MPH EngenderHealth FIGO panel, Post-partum contraception with a focus on post-partum

More information

LARC IN THE OFFICE BASE SETTING. Regina Lewis, DO Associate Professor of Family Medicine OSU Family Medicine

LARC IN THE OFFICE BASE SETTING. Regina Lewis, DO Associate Professor of Family Medicine OSU Family Medicine SHIFT HAPPENS! LARC IN THE OFFICE BASE SETTING Regina Lewis, DO Associate Professor of Family Medicine OSU Family Medicine 1. the effects of teen and unplanned pregnancies 2. types of LARC products 3.

More information

Expanding Access to Birth Control: Will Women Get the Care They Need?

Expanding Access to Birth Control: Will Women Get the Care They Need? Expanding Access to Birth Control: Will Women Get the Care They Need? Target Audience: Pharmacists ACPE#: 0202-0000-18-045-L01-P Activity Type: Application-based Target Audience: ACPE#: Activity Type:

More information

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to

the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put

More information

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community

Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community Maximizing LARC Availability: Bringing the Lessons of the CHOICE Project to Your Community Reproductive Health 2012 September 21, 2012 David Turok, MD/MPH Objectives Communicate to colleagues the reduction

More information

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project

Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Long-Acting Reversible Contraception: The Contraceptive CHOICE Project Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research Robert J. Terry Professor Department of Obstetrics & Gynecology Washington

More information

What s New in Adolescent Contraception?

What s New in Adolescent Contraception? What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017 Objectives Provide an update on contraception options for the adolescent

More information

CONFERENCE SCHEDULE. Demonstrate correct hand skills necessary for placement of the copper IUD and each of the three levonorgestrel IUDs.

CONFERENCE SCHEDULE. Demonstrate correct hand skills necessary for placement of the copper IUD and each of the three levonorgestrel IUDs. PRECONFERENCE SCHEDULES ATLANTA, GA } THURSDAY, NOVEMBER 1, 2018 PRECONFERENCE A (8:00 A.M. - 12:15 P.M.) IUD PLACEMENT FUNDAMENTALS: A PRACTICUM (Space is limited to 50 participants. Register early. This

More information

A study to evaluate and compare the expulsion, removal and continuation of post placental insertion of Cu 375 and CuT 380A in Indian women

A study to evaluate and compare the expulsion, removal and continuation of post placental insertion of Cu 375 and CuT 380A in Indian women 2018; 2(1): 33-38 ISSN (P): 2522-6614 ISSN (E): 2522-6622 Gynaecology Journal www.gynaecologyjournal.com 2018; 2(1): 33-38 Received: 10-11-2017 Accepted: 11-12-2017 Dr. Somila Xess Junior Resident, Department

More information

ParaGard T 380A INTRAUTERINE COPPER CONTRACEPTIVE PRESCRIBING INFORMATION DESCRIPTION CLINICAL PHARMACOLOGY INDICATIONS AND USAGE CONTRAINDICATIONS

ParaGard T 380A INTRAUTERINE COPPER CONTRACEPTIVE PRESCRIBING INFORMATION DESCRIPTION CLINICAL PHARMACOLOGY INDICATIONS AND USAGE CONTRAINDICATIONS % of Women Experiencing an Accidental Pregnancy within the First Year of Use % of Women Continuing Use at One Year Method (1) Typical Use 1 (2) Perfect Use 2 () (4) ParaGard T 80A INTRAUTERINE COPPER CONTRACEPTIVE

More information

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital

Contraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception

More information

Information for Informed Consent for Insertion of a Mirena IUD

Information for Informed Consent for Insertion of a Mirena IUD Information for Informed Consent for Insertion of a Mirena IUD What is an IUD (intrauterine Device)? An intrauterine device (IUD) is a plastic device that is placed into your uterus to prevent pregnancy.

More information

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.

1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. 1 2 1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. The contraceptive action of all IUDs is mainly in the uterine cavity. The major effect

More information

Time Topic Speaker Abbreviation

Time Topic Speaker Abbreviation 1. Programme Sunday, 4 th November 2018 Time Topic Speaker Abbreviation 08:00 Welcome, distribution materials 08:30 Overview of the Medical Eligibility Criteria (2015), and the Selected Practices Recommendations

More information

MDHHS: Coding and Billing for Contraceptive Services

MDHHS: Coding and Billing for Contraceptive Services 1 The correct answer is B. A separate preventive E/M service was provided and a 25 modifier is necessary. The correct code is 99385 based on Lisa being new to the practice and being between 18 and 39 years

More information

maybe it s time to With Your Current And move on to 100% hormone free, more than 99% effective Paragard (intrauterine copper contraceptive) IUD.

maybe it s time to With Your Current And move on to 100% hormone free, more than 99% effective Paragard (intrauterine copper contraceptive) IUD. maybe it s time to With Your Current And move on to 100% hormone free, more than 99% effective Paragard (intrauterine copper contraceptive) IUD. thinking about ParaGard (INTRAUTERINE COPPER CONTRACEPTIVE)?

More information

Development of an ipad waiting room app for contraceptive counseling in Title X clinics

Development of an ipad waiting room app for contraceptive counseling in Title X clinics Development of an ipad waiting room app for contraceptive counseling in Title X clinics Melissa Gilliam, MD, MPH Summer Martins, MPH Stephanie Mistretta, MA Jessyca Dudley, MPH Shirley Yan Disclosure The

More information

An Illustrative Communication Strategy for Contraceptive Implants

An Illustrative Communication Strategy for Contraceptive Implants An Illustrative Communication Strategy for Contraceptive Implants: Step 1 (Analyze the Situation) 1 An Illustrative Communication Strategy for Contraceptive Implants Step 1: Analyze the Situation Health

More information

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.

Welcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S. Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena

More information

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer

levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises

More information

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO

Effective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Effective Contraception Utilization Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Disclosures Contract Medical Director, EOCCO Objectives Illustrate how to best address contraception

More information

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit

Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain

More information

2

2 1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive

More information

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016

Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Contraception for Obese Women RENEE E. MESTAD, MD, MSCI ACOG DISTRICT II UPSTATE MEETING APRIL 29, 2016 Disclosure I am a Nexplanon trainer for Merck. Objectives Understand how obesity may affect pharmacokinetics

More information

LIVE PLACEMENT TRAINING WEBCAST

LIVE PLACEMENT TRAINING WEBCAST REGISTER FOR A LIVE PLACEMENT TRAINING WEBCAST Join us for a training webcast led by an expert speaker who brings extensive background in women s health. On this webcast, you can: Learn the steps for PARAGARD

More information

Fitting of an Intrauterine Device (IUD)

Fitting of an Intrauterine Device (IUD) PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is an IUD? An IUD is a small T-shaped plastic and copper device that is put into

More information

Postpartum Intrauterine Contraceptive Device (PPIUD) Services. Learner s Handbook

Postpartum Intrauterine Contraceptive Device (PPIUD) Services. Learner s Handbook Postpartum Intrauterine Contraceptive Device (PPIUD) Services Learner s Handbook ACCESS-FP is an associate award under the ACCESS Program, Associate Cooperative Agreement #GPO- A-00-05-00025-00, Reference

More information

Contraceptives. Kim Dawson October 2010

Contraceptives. Kim Dawson October 2010 Contraceptives Kim Dawson October 2010 Objectives: You will learn about: The about the different methods of birth control. How to use each method of birth control. Emergency contraception What are they?

More information

Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices

Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices The Journal of Reproductive Medicine Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices Vien C. Lam, M.D., Emily E. Hadley, M.D., Abbey B. Berenson, M.D., Ph.D., Jacqueline

More information

For more information, visit us online at PARAGARDAccessSolutions.com. To speak with a representative call PARAGARD ( ).

For more information, visit us online at PARAGARDAccessSolutions.com. To speak with a representative call PARAGARD ( ). Improve patient access with PARAGARD Access Solutions TM A comprehensive range of support services and resources designed to make access easier for your patients who choose PARAGARD. PARAGARD Direct is

More information

Population and Patient Perspectives on Shared Decision-Making: Acknowledging the Controversies

Population and Patient Perspectives on Shared Decision-Making: Acknowledging the Controversies Population and Patient Perspectives on Shared Decision-Making: Acknowledging the Controversies Christine Dehlendorf, MD, MAS Patty Cason RN, MS, FNP-BC Sonya Borrero, MD, MS Michaela Gonzalez BA Disclosures

More information

Intrauterine contraceptive devices (IUDs) are becoming

Intrauterine contraceptive devices (IUDs) are becoming Malpositioned Intrauterine Contraceptive Devices Risk Factors, Outcomes, and Future Pregnancies Kari P. Braaten, MD, MPH, Carol B. Benson, MD, Rie Maurer, MA, and Alisa B. Goldberg, MD, MPH OBJECTIVE:

More information

Contraception for Women and Couples with HIV. Knowledge Test

Contraception for Women and Couples with HIV. Knowledge Test Contraception for Women and Couples with HIV Knowledge Test Instructions: For each question below, check/tick all responses that apply. 1. Which statements accurately describe the impact of HIV/AIDS in

More information

Management of Emergency Contraception (EC)

Management of Emergency Contraception (EC) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Management of Emergency Contraception (EC) The risks and benefits of an IUD or oral EC should be discussed and documented (see appendix). Reasonable measures

More information

IS PARAGARD RIGHT FOR YOU?

IS PARAGARD RIGHT FOR YOU? IS PARAGARD RIGHT FOR YOU? Ask your doctor about the only reversible birth control that s more than % effective and 100% hormone free. What to Tell your Doctor How you feel about hormones How you feel

More information

Family Planning and Sexually Transmitted. Infections, including HIV

Family Planning and Sexually Transmitted. Infections, including HIV Infections, including HIV Family Planning and Sexually Transmitted Introduction To protect themselves, people need correct information about sexually transmitted infections (STIs), including HIV. Women

More information

WHAT ARE CONTRACEPTIVES?

WHAT ARE CONTRACEPTIVES? CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.

More information

M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH

M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH Unrestricted M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH Patients at imminent risk of exsanguination Manual aortic compression Resuscitative endovascular balloon occlusion of the aorta Uterine tourniquet

More information

POLICY & PROCEDURE DEFINITIONS: N/A POLICY:

POLICY & PROCEDURE DEFINITIONS: N/A POLICY: POLICY & PROCEDURE TITLE: Fertility Regulation Family Planning Scope/Purpose: To offer a wide range of approved methods for Family Planning services Division/Department: : All HealthPoint Clinics Policy/Procedure

More information

BEST PRACTICES IN CONTRACEPTIVE COUNSELING

BEST PRACTICES IN CONTRACEPTIVE COUNSELING Condition Sub-condition Combined pill, patch, ring Anemias a) Thalassemia 1 1 1 1 1 2 b) Sickle cell disease 2 1 1 1 1 2 c) Iron-deficiency anemia 1 1 1 1 1 2 Benign ovarian (including cysts) 1 1 1 1 1

More information

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine

Contraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to

More information

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization Draft Guidance for Industry and Food and Drug

More information

A Pharmacist s Update on the Efficacy, Safety and Role of Long-acting Reversible Contraception

A Pharmacist s Update on the Efficacy, Safety and Role of Long-acting Reversible Contraception A Pharmacist s Update on the Efficacy, Safety and Role of Long-acting Reversible Contraception Shareen Y. El-Ibiary, PharmD, FCCP, BCPS Professor of Pharmacy Practice Department of Pharmacy Practice Midwestern

More information

1. Which of the following is an addition to components of reproductive health under the new paradigm

1. Which of the following is an addition to components of reproductive health under the new paradigm Population Change and Public Health Exercise 11A 1. Which of the following is an addition to components of reproductive health under the new paradigm A. Safe motherhood B. Provision of family planning

More information

Cue Cards for Counseling Adolescents on Contraception

Cue Cards for Counseling Adolescents on Contraception Cue Cards for Counseling Adolescents on Contraception About the Cue Cards This set of contraceptive counseling cue cards was developed to support a range of providers (such as facility-based providers,

More information

유일하게 100% 무호르몬인 IUD( 자궁내피임장치 ) 입니다!

유일하게 100% 무호르몬인 IUD( 자궁내피임장치 ) 입니다! PARAGARD 사용을고려중이십니까? ( 동제자궁내피임장치 ) 유일하게 100% 무호르몬인 IUD( 자궁내피임장치 ) 입니다! PARAGARD 란? PARAGARD 는자궁내에삽입되어구리를배출함으로써최대 10 년까지임신을방지하는장치입니다. 이는자궁내장치 (Intrauterine Device,IUD) 라고도불리는피임방법입니다. PARAGARD 의작용방법 PARAGARD

More information

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER HEALTH ANALYSIS DEPARTMENT

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER HEALTH ANALYSIS DEPARTMENT NAVY AND MARINE CORPS PUBLIC HEALTH CENTER HEALTH ANALYSIS DEPARTMENT 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 757.953.0700 E-mail: health-analysis@nehc.mar.med.navy.mil Analysis of Long-Acting

More information

FACT SHEET: Copper IUD

FACT SHEET: Copper IUD FACT SHEET: Copper IUD How does the copper IUD help me? The copper IUD is a hormone-free option. If you don t like the copper IUD or you decide to get pregnant, your health care provider can remove the

More information

NIH Public Access Author Manuscript Contraception. Author manuscript; available in PMC 2012 November 1.

NIH Public Access Author Manuscript Contraception. Author manuscript; available in PMC 2012 November 1. NIH Public Access Author Manuscript Published in final edited form as: Contraception. 2011 November ; 84(5): 499 504. doi:10.1016/j.contraception.2011.01.022. Postplacental or delayed levonorgestrel intrauterine

More information